Risperdal Attorneys Serving Arlington

Sunday December 22, 2024

Gynecomastia, the growth of abnormally large breasts in males, has been associated with the antipsychotic medication Risperdal (or risperidone). Risperdal lawsuits allege that the risk of male breast growth in children and adolescents was concealed from consumers in Arlington and other U.S. markets. In addition, evidence shows the drug's manufacturer may have promoted Risperdal to physicians for use in young patients without FDA approval for such use. Our Risperdal attorneys are investigating whether the company's sales and marketing practices put young patients in Arlington at a heightened risk of gynecomastia.

If you or a loved one in Arlington suffered serious Risperdal side effects such as male breast growth, you may have important legal rights. Call (888) 849-5117 or use our online form to consult an experienced Risperdal lawyer and protect your rights.

Lawsuits Allege Illegal Promotion of Risperdal

In a September 2012 jury trial, former company manager Tone Jones testified about Johnson & Johnson's promotion of Risperdal to child psychiatrists. He testified that the company paid physicians to give favorable speeches, subsidized golf trips, and increased visits to doctors who treat children. According to Jones, these promotional efforts took place as early as 2003. The FDA did not approve Risperdal for use in children, however, until 2006 and 2007. If true, this type of "off-label" promotion may have subjected Arlington children and adolescents to Risperdal side effects such as gynecomastia without proper regulatory oversight by the FDA.

In fact, the former commissioner of the FDA submitted a report in a separate Risperdal trial affirming Jones's testimony. According to the report, the manufacturer promoted Risperdal for use in children and adolescents before it was FDA-approved, a violation of the Federal Food, Drug, and Cosmetic Act. The former official called such off-label promotion "deeply troubling" because "it undercuts the system and safeguards of drug regulation" designed to protect U.S. consumers in Arlington and nationwide.

Arlington Lawsuits Not Part of Risperdal Class Action

Drug related lawsuits of this nature are often believed to be in the form of a class action. Risperdal, however, is not the subject of a class action lawsuit for personal injuries like gynecomastia. Rather, each individual plaintiff from Arlington files a separate Risperdal lawsuit in the appropriate state or federal court. These individual claims are then compensated on a case-by-case basis according to the specific risperidone side effects and legal damages experienced by the plaintiff. Our Risperdal lawyers believe individual lawsuits permit better outcomes for Arlington claimants than could be achieved under a nationwide Risperdal class action.

Call Today for a Case Evaluation

Our Risperdal lawyers have years of experience in complex pharmaceutical litigation against powerful drug companies. The firm provides consultations at no cost and with no obligation. Call (888) 849-5117 or send a message online for a prompt evaluation of your Arlington Risperdal lawsuit and protect your legal rights.

Free Case Evaluation